Established
2009
Attendees
11,500
Speakers
1,700
Companies
2,050
The Precision Medicine World Conference (PMWC), in its 13th installment, will take place in Silicon Valley on January 22-24, 2018. The program will traverse innovative technologies, thriving initiatives, and clinical case studies that enable the translation of precision medicine into direct improvements in health care. Conference attendees will have an opportunity to learn first-hand about the latest developments and advancements in precision medicine and cutting-edge new strategies and solutions that are changing how patients are treated.
Agenda highlights:
- More than 70 sessions with 350+ thought-provoking, insightful talks that cover all facets of precision medicine
- Five tracks will showcase sessions on the latest advancements in precision medicine which include, but are not limited to:
- Advancements in liquid biopsy applications
- AI and machine learning opportunities and applications
- Big data and emerging technology applications that enable precision medicine
- Biomarker and companion diagnostics
- Cancer and rare disease diagnostics
- Clinical NGS applications
- Clinical trial developments
- Clinical-decision support
- CRISPR technologies
- Digital, mHealth, and Telehealth
- Drug discovery challenges and opportunities
- Economics and socio-political aspects of PM
- Immunotherapy applications
- Infectious disease ID and monitoring
- Large scale human genetics application in genomic medicine and drug discovery
- Liquid biopsy applications
- Metabolomics in precision medicine
- Overcoming data sharing
- Precision medicine initiatives
- The All of Us Research Program
- The human microbiome
- The importance of patient engagement
- Updates on data and regulatory policies
- Valued-based healthcare
- Wellness & Aging
- Up-and coming company showcases
The Precision Medicine World Conference (PMWC), in its 13th installment, will take place in Silicon Valley on January 22-24, 2018. The program will traverse innovative technologies, thriving initiatives, and clinical case studies that enable the translation of precision medicine into direct improvements in health care. Conference attendees will have an opportunity to learn first-hand about the latest developments and advancements in precision medicine and cutting-edge new strategies and solutions that are changing how patients are treated.
Agenda highlights:
- More than 70 sessions with 350+ thought-provoking, insightful talks that cover all facets of precision medicine
- Five tracks will showcase sessions on the latest advancements in precision medicine which include, but are not limited to:
- Advancements in liquid biopsy applications
- Artificial Intelligence and machine learning opportunities and applications
- Big data and emerging technology applications that enable precision medicine
- Biomarker and companion diagnostics
- Cancer and rare disease diagnostics
- Clinical NGS applications
- Clinical trial developments
- Clinical-decision support
- CRISPR technologies
- Digital, mHealth, and Telehealth
- Drug discovery challenges and opportunities
- Economics and socio-political aspects of PM
- Immunotherapy applications
- Infectious disease ID and monitoring
- Large scale human genetics application in genomic medicine and drug discovery
- Liquid biopsy applications
- Metabolomics in precision medicine
- Overcoming data sharing
- Precision medicine initiatives
- The All of Us Research Program
- The human microbiome
- The importance of patient engagement
- Updates on data and regulatory policies
- Valued-based healthcare
- Wellness & Aging
- Up-and coming company showcases
One track will be dedicated to the various aspects of the All of Us Research Program, while another session will focus on educating California’s legislators.
- A lineup of 350+ highly regarded speakers featuring pioneering researchers and authorities across the healthcare and biotechnology sectors – browse select PMWC 2017 SV recorded sessions
- Luminary and Pioneer Awards, honoring individuals who contributed, and continue to contribute, to the field of Precision Medicine
- 1500+ multidisciplinary attendees, from across the entire spectrum of healthcare, representing different types of companies, technologies, and medical centers with leadership roles in precision medicine
Confirmed thought leaders include:

Sir John Bell
Regius Professor of Medicine, Oxford University

Alan Ashworth
President, UCSF Helen Diller Family Comprehensive Cancer Center

Aris Baras
Vice President & Head, Regeneron Genetics Center

George Sledge
Professor, Division Chief, Stanford University Medical Center

Jeffrey Bluestone
CEO and President, Parker Institute for Cancer Immunotherapy

Christopher Ianelli
Founder and Chief Executive Officer, iSpecimen

Kenneth J. Pienta
Director, Brady Urological Institute, Johns Hopkins Medicine

Roy Beveridge
Senior Vice President & Chief Medical Officer, Humana

Kimberly Blackwell
Professor of Medicine, Assistant Prof. of Radiation Oncology, Duke Cancer Institute

Joshua Denny
Professor of Biomedical Informatics & Medicine, Vanderbilt University Medical Center

Edward S. Kim
Chair, Solid Tumor and Investigational Therapeutics, Levine Cancer Institute

Howard L. McLeod
Medical Director, Personalized Medicine Institute, Moffitt Cancer Center

Lee Newcomer
SVP, UnitedHealthcare Oncology and Genetics

Vinod Khosla
Partner and Founder of Khosla Ventures

Troy Brennan
Executive VP & CMO, CVS Health

Ira Mellman
VP, Cancer Immunology, Genentech
Registration: PMWC Conferences
Silicon Valley Jan 22-24, 2018






Having Trouble Registering? We accept all major credit cards. Select 'PayPal Check out' and press 'Pay with Debit or Credit Card'.
Click here or call (650)-961-8877 to contact the PMWC Team for Help.